CXCR-4 | CD20 | CD20/ CXCR-4 | IgA | IgG | IgA/IgG | CD45 | COX-2 | COX-2/ CD45 | (N) | |
TOTAL SAMPLE | 88.2 ± 2.2 | 58.0 ± 2.4 | 49.8 ± 2.5 | 90.9 ± 1.3 | 68.4 ± 3.7 | 61.0 ± 4.2 | 21.8 ± 2.7 | 60.2 ± 3.1 | 6.6 ± 1.9 | 54 |
(12.3 - 99.0) | (5.9 - 97.6) | (0.0 - 93.6) | (42.1 - 99.1) | (1.12 - 98.7) | (0.0 - 96.9) | (0.0 - 86.4) | (11.2 - 97.2) | (0.0 - 62.7) | ||
GENDER | ||||||||||
Male | 88.1 ± 3.3 | 64.4 ± 4.7 | 56.4 ± 4.5 | 88.1 ± 2.6 | 67.9 ± 5.3 | 59.3 ± 6.9 | 28.7 ± 4.3 | 65.2 ± 4.8 | 12.1 ± 3.5 | 23 |
(25.7 - 99.0) | (5.9 - 97.6) | (0.0 - 93.6) | (42.1 - 98.2) | (1.12 - 98.7) | (0.0 - 96.9) | (0.0 - 70.3) | (17.6 - 97.2) | (0.0 - 56.4) | ||
Female | 86.3 ± 3.9 | 58.2 ± 2.7 | 48.4 ± 3.8 | 93.1 ± 1.2 | 68.7 ± 5.2 | 62.4 ± 5.2 | 16.7 ± 3.2 | 57.3 ± 3.9 | 2.6 ± 2.0 | 31 |
(12.4 - 98.8) | (8.3 - 66.6) | (0.0 - 88.0) | (76.3 - 99.1) | (10.2 - 97.8) | (0.0 - 96.4) | (0.0 - 86.4) | (11.2 - 94.3) | (0.0 - 62.7) | ||
p value | 0.74 | 0.23 | 0.74 | 0.06 | 0.92 | 0.72 | 0.03 | 0.21 | 0.02 | |
RACE | ||||||||||
Caucasian | 93.0 ± 1.5 | 62.1 ± 4.0 | 55.5 ± 3.8 | 91.2 ± 1.9 | 73.6 ± 6.1 | 66.9 ± 6.1 | 31.3 ± 4.9 | 58.4 ± 5.5 | 11.6 ± 4.5 | 16 |
(78.3 - 99.0) | (41.5 - 96.6) | (38.7 - 93.6) | (91.5 - 99.1) | (10.2 - 98.7) | (9.4 - 96.9) | (2.3 - 70.3) | (26.2 - 97.2) | (0.0 - 56.4) | ||
African American | 85.9 ± 3.4 | 61.1 ± 3.0 | 50.7 ± 3.6 | 92.1 ± 1.2 | 67.4 ± 4.5 | 61.0 ± 4.8 | 18.0 ± 3.2 | 62.1 ± 3.7 | 4.0 ± 2.1 | 36 |
(12.4 - 98.8) | (21.5 - 97.6) | (0.0 - 88.0) | (70.5 - 98.7) | (19.1 - 97.8) | (0.0 - 95.6) | (0.0 - 86.4) | (11.2 - 97.0) | (0.0 - 62.7) | ||
p value | 0.001 | 0.01 | 0.035 | 0.001 | 0.034 | 0.001 | 0.046 | 0.142 | 0.197 |